Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders
Narayanappa Amruta, Wesley H. Chastain, Meshi Paz, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 58, pp. 1-15
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Post‐acute COVID‐19 syndrome (PCS) and health‐related quality of life (HRQoL)—A systematic review and meta‐analysis
Preeti Malik, Karan Patel, Cândida Pinto, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 1, pp. 253-262
Open Access | Times Cited: 534
Epidemiology of Parkinson’s Disease: An Update
Juan R. Deliz, Caroline M. Tanner, Paulina González-Latapí
Current Neurology and Neuroscience Reports (2024) Vol. 24, Iss. 6, pp. 163-179
Closed Access | Times Cited: 16
Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Gomaa Mostafa‐Hedeab, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 56
Amyloid processing in COVID‐19‐associated neurological syndromes
Oliver J. Ziff, Nicholas J. Ashton, Puja R. Mehta, et al.
Journal of Neurochemistry (2022) Vol. 161, Iss. 2, pp. 146-157
Open Access | Times Cited: 51
Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options
Yasaman Nazerian, Mobina Ghasemi, Younes Yassaghi, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109428-109428
Open Access | Times Cited: 51
Neurological complications associated with Covid‐19; molecular mechanisms and therapeutic approaches
Mohammad Mahboubi Mehrabani, Mohammad Sobhan Karvandi, Pedram Maafi, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 47
Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders
Kritika Tyagi, Prachi Rai, Anuj Gautam, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 30
Cardiovascular autonomic dysfunction in “Long COVID”: pathophysiology, heart rate variability, and inflammatory markers
Karina Carvalho Marques, Juarez Antônio Simões Quaresma, Luiz Fábio Magno Falcão
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 27
Assessing the Burden and Cost of COVID-19 Across Variants in Commercially Insured Immunocompromised Populations in the United States: Updated Results and Trends from the Ongoing EPOCH-US Study
Amita Ketkar, Vincent J. Willey, Lisa Glasser, et al.
Advances in Therapy (2024) Vol. 41, Iss. 3, pp. 1075-1102
Open Access | Times Cited: 11
SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19
Geidy E. Serrano, Jessica E. Walker, Cécilia Tremblay, et al.
Journal of Neuropathology & Experimental Neurology (2022) Vol. 81, Iss. 9, pp. 666-695
Open Access | Times Cited: 38
Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 1-7
Open Access | Times Cited: 37
Assessing the risk and costs of COVID-19 in immunocompromised populations in a large United States commercial insurance health plan: the EPOCH-US Study
Amita Ketkar, Vincent J. Willey, Michael Pollack, et al.
Current Medical Research and Opinion (2023) Vol. 39, Iss. 8, pp. 1103-1118
Open Access | Times Cited: 22
Potential convergence of olfactory dysfunction in Parkinson’s disease and COVID-19: The role of neuroinflammation
Hui Li, Junliang Qian, Youcui Wang, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102288-102288
Closed Access | Times Cited: 7
Mouse Adapted SARS-CoV-2 (MA10) Viral Infection Induces Neuroinflammation in Standard Laboratory Mice
Narayanappa Amruta, Saifudeen Ismael, Sarah R. Leist, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 114-114
Open Access | Times Cited: 23
Blood-brain barrier function in response to SARS-CoV-2 and its spike protein
Łukasz Suprewicz, Krzysztof Fiedoruk, Agata Czarnowska, et al.
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 1, pp. 14-25
Open Access | Times Cited: 13
Neurological damages in COVID‐19 patients: Mechanisms and preventive interventions
Sibani Sarkar, Subhajit Karmakar, Malini Basu, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 13
Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms
Tihamér Molnár, Réka Várnai, Dániel Schranz, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 19, pp. 4337-4337
Open Access | Times Cited: 28
Long-term cognitive performance and its relation to anti-inflammatory therapy in a cohort of survivors of severe COVID-19
Harmke B. Duindam, Roy P. C. Kessels, Bram van den Borst, et al.
Brain Behavior & Immunity - Health (2022) Vol. 25, pp. 100513-100513
Open Access | Times Cited: 22
COVID-19 and the Brain: The Neuropathological Italian Experience on 33 Adult Autopsies
Viscardo Paolo Fabbri, Mattia Riefolo, Tiziana Lazzarotto, et al.
Biomolecules (2022) Vol. 12, Iss. 5, pp. 629-629
Open Access | Times Cited: 19
Delivery of Theranostic Nanoparticles to Various Cancers by Means of Integrin-Binding Peptides
E. A. Egorova, Maxim P. Nikitin
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13735-13735
Open Access | Times Cited: 19
Acute and long-term effects of COVID-19 on brain and mental health: A narrative review
J. Douglas Bremner, Scott J. Russo, Richard J. Gallagher, et al.
Brain Behavior and Immunity (2024) Vol. 123, pp. 928-945
Closed Access | Times Cited: 4
Glioblastoma Management in the Post-COVID-19 Era: Challenges, Strategies, and Adaptations
Xiaohui Ren, Ling Qin
IntechOpen eBooks (2025)
Closed Access
Covid-19 interface with drug misuse and substance use disorders
Irma E. Cisneros, Kathryn A. Cunningham
Neuropharmacology (2021) Vol. 198, pp. 108766-108766
Open Access | Times Cited: 25
ATN-161 Ameliorates Ischemia/Reperfusion-induced Oxidative Stress, Fibro-inflammation, Mitochondrial damage, and Apoptosis-mediated Tight Junction Disruption in bEnd.3 Cells
Narayanappa Amruta, Gregory Bix
Inflammation (2021) Vol. 44, Iss. 6, pp. 2377-2394
Open Access | Times Cited: 24
Cognitive dysfunction associated with COVID-19: Prognostic role of circulating biomarkers and microRNAs
Marissa Alvarez, Erick Trent, Bruno de Souza Gonçalves, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top